U.S. Hospitality Stock News

Omega Healthcare Investors (OHI) is back in focus after Wells Fargo cut its rating to Equal Weight and trimmed its target, arguing the REIT’s valuation looks full at current prices for now. See our latest analysis for Omega Healthcare Investors. At a share price of $43.88, Omega Healthcare Investors has seen modest recent moves, with a 4.5% 90 day share price return and a 26.9% 1 year total shareholder return. This indicates that momentum has been building over the longer term despite shorter...

If you are wondering whether KLA's current share price still offers value after a strong run, this article will walk through what the numbers actually say about the stock. Over the last year, KLA returned 95.1%, with a 12.0% gain over the past month but a 5.6% decline in the last week, which may have shifted how investors think about both its upside and risk. Recently, KLA has been in focus as part of broader interest in semiconductor and chip equipment companies, with headlines frequently...

The Board of Directors of The Gorman-Rupp Company recently declared a quarterly cash dividend of US$0.19 per share, payable on March 10, 2026, to shareholders of record as of February 13, 2026. This dividend decision comes alongside evidence of strong multi-year revenue, backlog, and earnings expansion, suggesting the payout is being supported by solid underlying business momentum. Next, we will consider how this combination of a US$0.19 quarterly dividend and robust backlog growth shapes...

We note that the Midland States Bancorp, Inc. ( NASDAQ:MSBI ) Chief Information Officer, Kyle Mooney, recently sold...

In late January 2026, Medicare confirmed it would sharply scale back coverage of telehealth services to mainly rural areas and specific mental health uses, raising fresh questions about demand for Teladoc Health’s virtual care offerings. While Teladoc’s revenue base is still largely tied to commercial health plans rather than Medicare, the policy shift amplifies existing concerns about its BetterHelp user declines, competition and path to profitability. We’ll now examine how the Medicare...

Incyte (NasdaqGS:INCY) received a positive opinion from the European Medicines Agency's CHMP for Zynyz (retifanlimab) with chemotherapy as a first-line treatment for advanced squamous cell carcinoma of the anal canal. The opinion is based on Phase 3 data showing improved outcomes without new safety signals in this patient group. The CHMP decision is an important step in the EU regulatory process and could support broader availability of Zynyz for eligible patients. For you as an investor...

In January 2026, Bristow Group Inc. completed a private offering of US$500,000,000 in 6.750% senior secured notes due 2033, refinanced its 6.875% senior secured notes due 2028, and extended its asset-based revolving credit facility to 2031 with revised commitments. Days earlier, Electra.aero announced a binding pre-delivery payment agreement giving Bristow the first-year production delivery slots for Electra's EL9 hybrid-electric aircraft, highlighting Bristow's early move into...

Recent share performance and business snapshot Wynn Resorts (WYNN) has drawn investor attention after a period of mixed share performance, with the stock showing negative returns over the past week, month, and past 3 months, but a positive 1 year total return. The company reports revenue of US$7.1b and net income of US$504.3m, with both revenue and net income growth reported on an annual basis. Its value score of 4 and current price of US$107.45 give investors a starting point for assessing...

If you are wondering whether Albemarle's current share price still lines up with its fundamentals, you are in the right place for a clear look at value. Albemarle's stock has moved sharply in both directions recently, with a 10% decline over the last 7 days, an 18.6% gain over the last 30 days, and a 106.9% return over the last year. Over a 3 year period the return sits at a 37.9% decline, and over 5 years the return is 15.2%. Recent coverage around Albemarle has focused on its role in...

Roper Technologies (ROP) just closed out 2025 with higher year-over-year revenue and free cash flow, but its latest earnings release, softer 2026 guidance, and segment pressures have clearly weighed on recent investor sentiment. See our latest analysis for Roper Technologies. The share price reaction has been sharp, with a 7 day share price return of 8.93% and a 30 day share price return of 14.57%, contributing to a 1 year total shareholder return of 35.08%. This may indicate fading momentum...

Johnson & Johnson (JNJ) is back in focus after a run of upbeat news, including strong fourth quarter and full year 2025 results, fresh 2026 sales guidance, and new FDA approval for DARZALEX FASPRO. See our latest analysis for Johnson & Johnson. Those updates have come alongside a strong share price run, with a 90 day share price return of 22.01% and a 1 year total shareholder return of 53.93%. This suggests that momentum has been building as investors reassess growth potential and litigation...

Enterprise Products Partners (NYSE:EPD) plans to cut capital spending in 2026 after a period of sizable investment. The company has announced a larger share repurchase program aimed at returning more cash to unitholders. Management also outlined greater flexibility for future dividend growth, subject to conditions over time. Enterprise Products Partners, which last closed at $33.19, has delivered a 127.0% return over the past 5 years and 59.2% over the past 3 years. The partnership has also...

Readers hoping to buy Weatherford International plc ( NASDAQ:WFRD ) for its dividend will need to make their move...

Context around Federal National Mortgage Association Federal National Mortgage Association (FNMA) has been drawing attention after recent share price moves, with the stock around $8.19 and returns showing mixed signals across the past week, month, past 3 months, and year. See our latest analysis for Federal National Mortgage Association. Recent trading has been weak, with a 1 day share price return of about 2% lower and a 30 day share price return of roughly 26% lower. However, the 1 year...

Synchrony Financial (SYF) is back in focus after its Q4 2025 earnings, where net income of $751 million and record purchase volume above $49 billion met a softer revenue line and cautious 2026 commentary. See our latest analysis for Synchrony Financial. The Q4 release and cautious 2026 commentary have been followed by a sharp pullback, with a 30 day share price return of a 14.2% decline and a year to date share price return matching that move. At the same time, the 1 year total shareholder...

In recent months, Teekay Tankers has drawn attention as analysts raised earnings estimates, highlighted strong quarterly results, and assigned top-tier ratings, reflecting increasing confidence in its operational performance. An interesting angle is how Teekay Tankers’ upgraded Zacks Rank and strong momentum score align with broad analyst optimism about its earnings prospects. With recent gains and growing focus on earnings estimate upgrades, we will examine how this shapes Teekay Tankers’...

Rivian Automotive (NasdaqGS:RIVN) has started producing manufacturing validation units of its new R2 mid-size SUV. The company continues to target the first half of 2026 for initial R2 deliveries. R2 is designed as a lower priced EV aimed at expanding Rivian's potential customer base. Recent actions include cost cutting measures and a partnership with Volkswagen to support future growth plans. Rivian, known for its R1T pickup and R1S SUV, is using the R2 to move closer to the mass market...

In January 2026, BitMine Immersion Technologies, Inc. terminated President Erik Nelson without cause under a board-approved separation agreement and secured stockholder approval to increase its authorized common shares from 500,000,000 to 50,000,000,000. At the same time, BitMine’s decision to concentrate its treasury in Ethereum, amassing over 4.2 million ETH and pursuing a Made-in-America Validator Network, has tied its corporate trajectory closely to crypto market swings. We’ll now...

Lockheed Martin (NYSE:LMT) has secured expanded long term agreements with the U.S. Department of War to sharply increase production of its THAAD and PAC-3 missile systems. The company is committing capital to a new Munitions Acceleration Center focused on advanced manufacturing for defense programs. Separately, Lockheed Martin has joined EMBERPOINT™, a collaborative AI driven wildfire response initiative with utilities and tech partners. For investors watching NYSE:LMT, these moves come...

Brookfield Business (BBUC) just paired its 2025 earnings release with an update on a broad corporate reorganization, capital recycling activity above US$2b, debt reduction, and four acquisitions, including a planned Fosber purchase in packaging machinery. See our latest analysis for Brookfield Business. These announcements come after a mixed stretch for the stock, with a 1-day share price return of 1.08% taking the share price to $35.66. The 30 day share price return is 2.03% lower, yet the 1...

NVIDIA (NasdaqGS:NVDA) is investing $2b in CoreWeave to support an AI infrastructure buildout targeting over 5 gigawatts of data center capacity by 2030. The company is expanding its collaboration with CoreWeave to supply AI compute for enterprise customers. NVIDIA also launched Earth-2, an open AI weather and climate modeling platform aimed at broadening access to advanced forecasting tools. NVIDIA, trading at $191.13, has seen very large multi year share price gains, including a 59.2%...

Hawthorn Bancshares, Inc. ( NASDAQ:HWBK ) will increase its dividend from last year's comparable payment on the 1st of...

Recent data showing a second consecutive month of Las Vegas Strip gross gaming revenue declines is drawing attention to MGM Resorts International (MGM) because of its heavy Strip exposure, leveraged balance sheet, and distress-zone Altman Z-Score. See our latest analysis for MGM Resorts International. The recent Las Vegas Strip revenue softness and MGM's balance sheet risks come against a mixed price backdrop, with a 30 day share price return of an 8.08% decline contrasting with a 90 day gain...

In recent days, ATRenew received an analyst upgrade from Wall Street Zen to a “strong-buy” rating, while Weiss Ratings reaffirmed its “hold (c-)” stance, alongside fresh activity from institutional investors and hedge funds. This mix of stronger analyst conviction and rising institutional interest highlights a growing divergence in professional views on ATRenew’s prospects. Next, we’ll examine how the analyst upgrade and shifting institutional interest shape ATRenew’s investment narrative...